Boleslaw Osinski

This inventor holds 11 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Tempus Labs, Inc., Tempus Ai, Inc.. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Boleslaw Osinski. Retrieved from https://idiyas.com/inventor/boleslaw-osinski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 3)

EPO Patents = 1 (Patent Applications = 4)

Average Co-Inventor Count = 7.9

ph-index = 6

Forward Citations = 80(Granted Patents)

Company Filing History:

Years Active: 2021-2026

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12524826 - Determining biomarkers from histopathology slide images (2026-01-13),

2. 12165236 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2024-12-10),

3. 11935152 - Determining biomarkers from histopathology slide images (2024-03-19),

4. 11682098 - Determining biomarkers from histopathology slide images (2023-06-20),

5. 11610307 - Determining biomarkers from histopathology slide images (2023-03-21),

6. 11348661 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2022-05-31),

7. 11348240 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2022-05-31),

8. 11348239 - Predicting total nucleic acid yield and dissection boundaries for histology slides (2022-05-31),

9. 11263748 - Determining biomarkers from histopathology slide images (2022-03-01),

10. 10991097 - Artificial intelligence segmentation of tissue images (2021-04-27),

11. 10957041 - Determining biomarkers from histopathology slide images (2021-03-23),

Title: Boleslaw Osinski: Innovator in Histopathology

Introduction

Boleslaw Osinski is a distinguished inventor based in Chicago, IL, known for his significant contributions to the field of histopathology. With a total of 10 patents to his name, he has made remarkable strides in developing methods and systems that enhance the analysis and interpretation of tissue samples.

Latest Patents

Among his latest innovations, Osinski has patented a method for predicting total nucleic acid yield and dissection boundaries for histology slides. This method qualifies specimens prepared on hematoxylin and eosin (H&E) slides by assessing expected nucleic acid yields for tumor cells, while also providing associated unstained slides for subsequent nucleic acid analysis. Additionally, he has developed a system for determining biomarkers from histopathology slide images. This system identifies biomarkers in digital images of H&E-stained slides, utilizing processors and electronic networks to predict biomarker presence through processed segmented tile images.

Career Highlights

Boleslaw Osinski's professional journey has led him to work with notable companies, including Tempus Labs, Inc. and Tempus AI, Inc. His experiences in these organizations have helped him advance technologies that are vital for medical diagnostics and research.

Collaborations

Throughout his career, Osinski has collaborated with distinguished coworkers such as Stephen Yip and Irvin Ho. These partnerships have played an essential role in fostering innovation within the field and enhancing the quality of research conducted in histopathology.

Conclusion

In conclusion, Boleslaw Osinski's work has had a profound impact on the field of histopathology, characterized by his innovative patents and collaborations with industry professionals. His dedication to advancing medical technology continues to pave the way for improved diagnostic methods and research applications.

Profile summary based on public USPTO records.